市场调查报告书
商品编码
1479110
雷射诱导击穿光谱市场:现况分析与预测(2023-2030)Laser-Induced Breakdown Spectroscopy Market: Current Analysis and Forecast (2023-2030) |
由于产品推出的增加,雷射诱导击穿光谱市场预计将以 6.3% 左右的速度稳定成长。 例如,Hamamatsu Photonics于2023年9月发布了最新的光谱仪 "OPAL-Luxe C16736-01" 。 在预测期内,有几个因素正在推动市场成长,例如医疗保健领域 IT 基础设施开发的进步。 除此之外,雷射诱导击穿光谱技术的进步也正在以稳定的速度推动雷射诱导击穿光谱市场。
依产品类型划分,市场分为手持设备和桌上型设备。 到 2022 年,手持设备将因便携性、易用性和技术进步而主导市场。 手持式雷射诱导击穿光谱 (LIBS) 是一种用于元素分析的技术。 高能量雷射脉衝聚焦在样品上,产生微等离子体并发射光。 分析发出的光以确定样品的元素组成。 手持式仪器使 LIBS 变得便携,适用于环境监测、法医分析和工业品质控制等现场应用。 因此,在产品类型中,手持设备细分市场在2022年占据了重要的市场占有率。
根据最终用户,市场分为学术/研究机构、製药/生技公司等。 由于患有癌症和骨质疏鬆症等慢性疾病的患者数量不断增加,预计製药和生物技术公司部门在预测期内将占据重要的市场占有率。 例如,根据世界卫生组织 (WHO) 的数据,癌症是全球主要死亡原因,2020 年约有 1,000 万人死于癌症,约占死亡人数的六分之一。 製药和生物技术公司越来越多地在其研究、开发和品质控製过程中利用 LIBS。 LIBS 具有快速分析、最少的样品製备和无损性等优点,使其在这些行业中具有价值。 在製药业,LIBS 可用于配方、原料和污染物的元素分析。 生物技术公司依靠 LIBS 进行各种应用,包括分析生物材料、监测发酵过程和表征生物样品。 因此,在预测期内,製药和生物技术公司类别将在最终用户中表现出更高的复合年增长率。
为了更瞭解雷射诱导击穿光谱的市场介绍,市场包括北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙、义大利、欧洲其他地区)、亚洲太平洋地区。 在当前情况下,由于癌症和骨质疏鬆症等慢性疾病病例急剧增加、研发活动支出增加、研究举措加强、对创新进展的投资以及企业合作的增加,北美地区预计将在 2022 年实现增长。它正在主导市场。 例如,根据2021 年5 月发表在《Science Direct》上的一项案例研究,事实证明,雷射诱导击穿光谱对于植物生物学家确定美国环境中农药和其他有害物质的毒理学作用非常有用,它已成为一种简单的方法。 因此,依地区划分,北美将在 2022 年占据较大市场占有率。
该市场的主要参与者包括 Thermo Fisher Scientific Inc.、SciAps, Inc.、Bruker Corporation、Princeton Instruments、Avantes 和 Applied Spectra。Laser-induced breakdown spectroscopy (LIBS) is an analytical technique used to determine the elemental composition of materials. It involves focusing a high-energy laser pulse onto a sample, which creates a micro-plasma or spark. This plasma emits light, which is then analyzed to identify the elements present in the sample based on their characteristic emission spectra. LIBS is used in various fields including laboratory assays, environmental monitoring, geological analysis, material science, archaeology, and industrial quality control due to its rapid and non-destructive nature. The increasing demand for quality control & process optimization and the LIBS's ability of non-destructive and rapid analysis lead to the market's growth. Several other factors, such as rising research & development activities, expanded applications in various industries like energy, metal & pharmaceutical, rising regulatory support, and a surge in government collaborations & partnerships are driving the laser-induced breakdown spectroscopy market globally.
The Laser-Induced Breakdown Spectroscopy Market is expected to grow at a steady rate of around 6.3% owing to the rising product launches. For instance, in September 2023, Hamamatsu Photonics launched its latest Spectrometer - the OPAL-Luxe C16736-01 which has applications like photoluminescence spectroscopy or laser-induced breakdown spectroscopy (LIBS). Several factors, including rising development of IT infrastructure in healthcare are driving the market's growth during the forecast period. Apart from this, technological advancements in laser-induced breakdown spectroscopy are also driving this market of laser-induced breakdown spectroscopy at a steady rate.
Based on the product type, the market is bifurcated into handheld and desktop. The handheld segment dominated the market in the year 2022 owing to technological advancements along with portability and user-friendly nature. Handheld laser-induced breakdown spectroscopy (LIBS) is a technique used for elemental analysis. It involves focusing a high-energy laser pulse onto a sample, creating a micro-plasma, which emits light. This emitted light is then analyzed to determine the elemental composition of the sample. Handheld devices make LIBS portable and suitable for in-field applications like environmental monitoring, forensic analysis, and industrial quality control. Thus, among the product types, the handheld segment held a significant market share in 2022.
Based on the end user, the market is categorized into academic & research institutes, pharmaceuticals & biotechnology companies, and others. The pharmaceuticals & biotechnology companies segment is expected to hold a significant share of the market in the forecast period owing to the rising chronic disease cases like cancer and osteoporosis. For instance, according to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Pharmaceutical and biotechnological companies are increasingly utilizing laser-induced breakdown spectroscopy (LIBS) in their research, development, and quality control processes. LIBS offers several advantages such as rapid analysis, minimal sample preparation, and non-destructive nature, making it valuable in these industries. In pharmaceuticals, LIBS can be employed for elemental analysis of drug formulations, raw materials, and contaminants detection. Biotechnological companies utilize LIBS for various applications including analysis of biomaterials, monitoring of fermentation processes, and characterization of biological samples. Thus, the pharmaceuticals & biotechnology companies category will witness a higher CAGR amongst end users during the forecast period.
For a better understanding of the market adoption of laser-induced breakdown spectroscopy, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of chronic diseases like cancer & osteoporosis, rising expenditure on research & development activities, rising research initiatives, investments in introducing innovative advancements, and rising company collaborations. For instance, according to a case study published in Science Direct in May 2021, laser-induced breakdown spectroscopy emerged as a straightforward bioimaging tool for plant biologists for assessment of photon-upconversion nanoparticles in Brassica oleracea L. plant, which is a plant species that belongs to ten recommended species by the United States Environmental Protection Agency for the determination of toxicological effects of pesticides and other toxic substances. Thus, amongst regions, North America held a significant share of the market in 2022.
Some of the major players operating in the market include Thermo Fisher Scientific Inc.; Hitachi High-Tech Analytical Science; SciAps, Inc.; Rigaku, Bruker Corporation; TSI; Princeton Instruments; Avantes; B&W Tek; Applied Spectra; SECOPTA analytics GmbH.